Rick Schnellmann was issued a renewal of his R01 grant from the National Institutes of Health (NIH) for the study “Mitochondrial Biogenesis Promotes Recovery from Oxidant Injury” and also was awarded a Small Business Technology Transfer (STTR) grant for “Urinary Biomarkers of Renal Mitochondrial Dysfunction.” STTR grants require partnership between small business concern and a research institution and award research that has the potential for commercialization.  

Schnellmann, the chair of the Department of Drug Discovery and Biomedical Sciences (DDBS), is a nationally-known expert on oxidative stress signaling and is co-principle investigator of a $10.5 million grant for the Center of Biomedical Research Excellence (COBRE) in Oxidants, Redox Balance, and Stress Signaling. His research is focused on the development of therapeutic agents that prevent cell death and promote cell repair and regeneration. 

The winner of the 2013 Society of Toxicology Education Award and named MUSC Eminent Scholar in 2007, Schnellmann was named MUSC Distinguished University Professor in 2012. This honor, granted to just 36 educators in MUSC's history, is the highest academic distinction granted by the MUSC Board of Trustees.